G. Verhoef

Stromal Gene Signatures in Large-B-Cell Lymphomas

Georg Lenz, George W. Wright, Sandeep S. Davé et al. · New England Journal of Medicine · 2008 · 1.8K citations · Full text

Medicine, Oncology, Pathology +16

Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study

Johan Maertens, Koen Theunissen, G. Verhoef et al. · Clinical Infectious Diseases · 2005 · 593 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Low-Dose 5-Aza-2′-Deoxycytidine, a DNA Hypomethylating Agent, for the Treatment of High-Risk Myelodysplastic Syndrome: A Multicenter Phase II Study in Elderly Patients

P. Wijermans, Michael Lübbert, G. Verhoef et al. · Journal of Clinical Oncology · 2000 · 571 citations

Medicine, Oncology, Pharmacology +17

Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin’s lymphoma

Karoline Spaepen, Sigrid Stroobants, Patrick Dupont et al. · Annals of Oncology · 2002 · 409 citations · Full text

Medicine, Nuclear Medicine, Oncology +13

Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma

M. Dreyling, Franck Morschhauser, Krimo Bouabdallah et al. · Annals of Oncology · 2017 · 272 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11